bioRxiv Science⌕ Search

Biology subjects

Solis, L. M.

Publications and source records attributed to Solis, L. M..

6 recordsLinked to original sources

EnhancerDetector: Enhancer Discovery from Human to Fly via Interpretable Deep Learning

BackgroundDeciphering how enhancers encode regulatory information in DNA remains a central genomics challenge, as sequencing outpaces functional annotation. A key question is whether enhancers possess an intrinsic, sequence-based "enhancerness" distinguishing them from other regions, independent of species, cell type, or assay. Confirming its existence and learnability is both biologically fundamental and essential for scalable genome annotation. ResultsWe introduce EnhancerDetector, a convolutional neural network-based framework for cross-species enhancer prediction that combines high accuracy with biological interpretability. Trained on human data, EnhancerDetector achieves strong performance across human, mouse, and fly datasets, consistently outperforming existing methods in precision and F1. It generalizes to datasets generated using diverse experimental assays. Unlike chromatin feature-based predictors requiring complex post hoc thresholding, EnhancerDetector directly outputs enhancer probability scores from short sequence windows, simplifying enhancer discovery workflows. An ensemble strategy further improves prediction reliability by reducing false positives. EnhancerDetector supports fine-tuning on new species and retains strong performance even when adapted with as few as 20,000 enhancer sequences, making it ideal for newly sequenced genomes with limited experimental data. For interpretability and visualization, we apply class activation maps to identify sequence regions predictive of enhancer activity. Experimental validation in transgenic flies confirms the predictive power of EnhancerDetector : five of six tested candidates drove reporter expression, and four exhibited expression patterns supported by prior literature. These analyses highlight distinct sequence and contextual features that confer what we term "enhancerness:" enhancer sequences possess a characteristic, identifiable signature. ConclusionsEnhancerDetector provides a sequence-based and interpretable framework for enhancer discovery across species and experimental contexts. Our results support the presence of recurring enhancer-associated sequence features that can be learned from DNA sequence and transferred across genomes. By combining cross-species prediction, fine-tuning, model interpretation, and experimental validation, EnhancerDetector offers a practical approach for prioritizing candidate enhancers in well-studied genomes. These features position EnhancerDetector as a useful first-stage annotation tool for identifying putative enhancers in newly sequenced genomes with limited experimental data.

bioinformatics↗

Elucidating immune-related gene transcriptional programs via factorization of large-scale RNA-profiles

Recent developments in immunotherapy, including immune checkpoint blockade (ICB) and adoptive cell therapy, have encountered challenges such as immune-related adverse events and resistance, especially in solid tumors. To advance the field, a deeper understanding of the molecular mechanisms behind treatment responses and resistance is essential. However, the lack of functionally characterized immune-related gene sets has limited data-driven immunological research. To address this gap, we adopted non-negative matrix factorization on 83 human bulk RNA-seq datasets and constructed 28 immune-specific gene sets. After rigorous immunologist-led manual annotations and orthogonal validations across immunological contexts and functional omics data, we demonstrated that these gene sets can be applied to refine pan-cancer immune subtypes, improve ICB response prediction and functionally annotate spatial transcriptomic data. These functional gene sets, informing diverse immune states, will advance our understanding of immunology and cancer research.

bioinformatics↗

EnhancerTracker: Comparing cell-type-specific enhancer activity of DNA sequence triplets via an ensemble of deep convolutional neural networks

MotivationTranscriptional enhancers -- unlike promoters -- are unrestrained by distance or strand orientation with respect to their target genes, making their computational identification a challenge. Further, there are insufficient numbers of confirmed enhancers for many cell types, preventing robust training of machine-learning-based models for enhancer prediction for such cell types. ResultsWe present EnhancerTracker, a novel tool that leverages an ensemble of deep separable convolutional neural networks to identify cell-type-specific enhancers with the need of only two confirmed enhancers. EnhancerTracker is trained, validated, and tested on 52,789 putative enhancers obtained from the FANTOM5 Project and control sequences derived from the human genome. Unlike available tools, which accept one sequence at a time, the input to our tool is three sequences; the first two are enhancers active in the same cell type. EnhancerTracker outputs 1 if the third sequence is an enhancer active in the same cell type(s) where the first two enhancers are active. It outputs 0 otherwise. On a held-out set (15%), EnhancerTracker achieved an accuracy of 64%, a specificity of 93%, a recall of 35%, a precision of 84%, and an F1 score of 49%. Availability and implementationhttps://github.com/BioinformaticsToolsmith/EnhancerTracker Contacthani.girgis@tamuk.edu

bioinformatics↗

An atlas of epithelial cell states and plasticity in lung adenocarcinoma

Understanding cellular processes underlying early lung adenocarcinoma (LUAD) development is needed to devise intervention strategies1. Here we studied 246,102 single epithelial cells from 16 early-stage LUADs and 47 matched normal lung samples. Epithelial cells comprised diverse normal and cancer cell states, and diversity among cancer cells was strongly linked to LUAD-specific oncogenic drivers. KRAS mutant cancer cells showed distinct transcriptional features, reduced differentiation and low levels of aneuploidy. Non-malignant areas surrounding human LUAD samples were enriched with alveolar intermediate cells that displayed elevated KRT8 expression (termed KRT8+ alveolar intermediate cells (KACs) here), reduced differentiation, increased plasticity and driver KRAS mutations. Expression profiles of KACs were enriched in lung precancer cells and in LUAD cells and signified poor survival. In mice exposed to tobacco carcinogen, KACs emerged before lung tumours and persisted for months after cessation of carcinogen exposure. Moreover, they acquired Kras mutations and conveyed sensitivity to targeted KRAS inhibition in KAC-enriched organoids derived from alveolar type 2 (AT2) cells. Last, lineage-labelling of AT2 cells or KRT8+ cells following carcinogen exposure showed that KACs are possible intermediates in AT2-to-tumour cell transformation.

cancer biology↗

Multidimensional single-cell analysis identifies a role of CD2-CD58 interactions for clinical antitumor T cell responses

The in vivo persistence of adoptively transferred T cells is predictive of anti-tumor response. Identifying functional properties of infused T cells that lead to in vivo persistence and tumor eradication has remained elusive. We profiled CD19-specific CAR T cells that comprise the infusion products used to treat large B cell lymphomas using high-throughput single-cell technologies based on Timelapse Imaging Microscopy In Nanowell Grids (TIMING) that integrates killing, cytokine secretion, and transcriptional profiling. Our results show that the directional migration of CD19-specific CAR T cells is correlated with polyfunctionality. We identified that CD2 on T cells is associated with directional migration and that the interaction between CD2 on T cells and CD58 on lymphoma cells accelerates killing and serial killing. Consistent with this, we observed elevated CD58 expression on pre-treatment tumor samples in patients with relapsed or refractory large B cell lymphomas treated with CD19-specific CAR T cell therapy was associated with complete clinical response and survival. These results highlight the importance of studying dynamic T-cell tumor cell interactions in identifying optimal antitumor responses. KEY POINTS- Profiling patient infusion products revealed that polyfunctional CAR T cells show directional migration, which is associated with higher CD2 expression - The ligand for CD2, CD58 is expressed at higher levels in the tumors of lymphoma patients who respond better to CAR T cell treatment

immunology↗

Resolving the spatial and cellular architecture of lung adenocarcinoma by multi-region single-cell sequencing

Little is known of the geospatial architecture of individual cell populations in lung adenocarcinoma (LUAD) evolution. Here, we perform single-cell RNA sequencing of 186,916 cells from 5 early-stage LUADs and 14 multi-region normal lung tissues of defined spatial proximities from the tumors. We show that cellular lineages, states, and transcriptomic features geospatially evolve across normal regions to LUADs. LUADs also exhibit pronounced intratumor cell heterogeneity within single sites and transcriptional lineage-plasticity programs. T regulatory cell phenotypes are increased in normal tissues with proximity to LUAD, in contrast to diminished signatures and fractions of cytotoxic CD8+ T cells, antigen-presenting macrophages and inflammatory dendritic cells. We further find that the LUAD ligand-receptor interactome harbors increased expression of epithelial CD24 which mediates pro-tumor phenotypes. These data provide a spatial atlas of LUAD evolution, and a resource for identification of targets for its treatment. Statement of significanceThe geospatial ecosystem of the peripheral lung and early-stage LUAD is not known. Our multi-region single-cell sequencing analyses unravel cell populations, states, and phenotypes in the spatial and ecological evolution of LUAD from the lung that comprise high-potential targets for early interception.

cancer biology↗